http://www.prnewswire.com/rss/policy-public-interest/fda-approval-news.rss Press Releases from PR Newswire about FDA Approval en-us Tue, 21 May 2013 22:31:47 EDT Tue, 21 May 2013 10:00:00 EDT http://www.prnewswire.com/news-releases/bausch--lomb-receives-fda-approval-for-the-trulign-toric-posterior-chamber-intraocular-lens-208301281.html http://www.prnewswire.com/news-releases/bausch--lomb-receives-fda-approval-for-the-trulign-toric-posterior-chamber-intraocular-lens-208301281.html Tue, 21 May 2013 10:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/bioelectronics-presents-fda-reclassification-panel-208287161.html http://www.prnewswire.com/news-releases/bioelectronics-presents-fda-reclassification-panel-208287161.html Tue, 21 May 2013 08:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/hologic-receives-fda-approval-for-a-new-low-dose-3d-mammography-breast-tomosynthesis-solution-for-breast-cancer-screening-208285781.html http://www.prnewswire.com/news-releases/hologic-receives-fda-approval-for-a-new-low-dose-3d-mammography-breast-tomosynthesis-solution-for-breast-cancer-screening-208285781.html Tue, 21 May 2013 08:15:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/muscle-warfare-a-wholly-owned-subsidiary-of-embark-holdings-embk-passes-inspection-by-the-fda-208130411.html http://www.prnewswire.com/news-releases/muscle-warfare-a-wholly-owned-subsidiary-of-embark-holdings-embk-passes-inspection-by-the-fda-208130411.html Mon, 20 May 2013 07:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-study-shows-full-spectrum-endoscopy-procedure-reduces-the-miss-rate-of-adenomas-during-colonoscopy-207993801.html http://www.prnewswire.com/news-releases/new-study-shows-full-spectrum-endoscopy-procedure-reduces-the-miss-rate-of-adenomas-during-colonoscopy-207993801.html Sat, 18 May 2013 10:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/fda-sets-17-july-2013-for-moxduo-advisory-committee-meeting-207853971.html http://www.prnewswire.com/news-releases/fda-sets-17-july-2013-for-moxduo-advisory-committee-meeting-207853971.html Fri, 17 May 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/thoratec-announces-fda-approval-of-heartmate-ii-pocket-controller-207848071.html http://www.prnewswire.com/news-releases/thoratec-announces-fda-approval-of-heartmate-ii-pocket-controller-207848071.html Fri, 17 May 2013 08:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/oramed-receives-fda-clearance-to-initiate-oral-insulin-trials-in-the-us-207846851.html http://www.prnewswire.com/news-releases/oramed-receives-fda-clearance-to-initiate-oral-insulin-trials-in-the-us-207846851.html Fri, 17 May 2013 07:50:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/mylan-launches-generic-tricor-tablets-207845161.html http://www.prnewswire.com/news-releases/mylan-launches-generic-tricor-tablets-207845161.html Fri, 17 May 2013 07:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/syneron-presente-ses-innovations-pour-le-remodelage-corporel-207693751.html http://www.prnewswire.com/news-releases/syneron-presente-ses-innovations-pour-le-remodelage-corporel-207693751.html Thu, 16 May 2013 09:00:00 EDT YOKNEAM, Israël, May 16, 2013 /PRNewswire/ --   Des possibilités de traitement élargies, une réduction du temps de traitement et une amélioration de l'expérience globale avec les systèmes UltraShape V3 et VelaShape II Syneron Medical Ltd. (NASDAQ...

]]>

]]> PRNewswire fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/syneron-stellt-erweiterungen-fur-seine-innovativen-body-shaping-produkte-vor-207693991.html http://www.prnewswire.com/news-releases/syneron-stellt-erweiterungen-fur-seine-innovativen-body-shaping-produkte-vor-207693991.html Thu, 16 May 2013 09:00:00 EDT JOKNE'AM, Israel, May 16, 2013 /PRNewswire/ -- Umfangreichere Behandlungsmöglichkeiten, kürzere Behandlungszeiten und ein verbessertes Gesamterlebnis mit den UltraShape- und VelaShape-Systemen Syneron Medical Ltd. (NASDAQ:ELOS), der weltweit führende Anbieter von...

]]>

]]> PRNewswire de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/syneron-presenta-mejoras-dentro-de-sus-innovadores-productos-de-remodelacion-corporal-207694471.html http://www.prnewswire.com/news-releases/syneron-presenta-mejoras-dentro-de-sus-innovadores-productos-de-remodelacion-corporal-207694471.html Thu, 16 May 2013 09:00:00 EDT YOKNEAM, Israel, May 16, 2013 /PRNewswire/ -- Amplía las opciones de tratamiento, reduce el tiempo de la sesión y mejora la experiencia general con los sistemas UltraShape y VelaShape Syneron Medical Ltd. (NASDAQ:ELOS), principal compañía global de equipos medico-...

]]>

]]> PRNewswire es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/syneron-presenta-i-miglioramenti-ai-suoi-innovativi-prodotti-per-il-rimodellamento-del-corpo-207693841.html http://www.prnewswire.com/news-releases/syneron-presenta-i-miglioramenti-ai-suoi-innovativi-prodotti-per-il-rimodellamento-del-corpo-207693841.html Thu, 16 May 2013 09:00:00 EDT YOKNEAM, Israele, May 16, 2013 /PRNewswire/ --  Più funzionalità ed efficienza, tempo di trattamento ridotto, e una migliore esperienza complessiva con i sistemi UltraShape e VelaShape Syneron Medical Ltd. (NASDAQ:ELOS), azienda leader globale per i dispositivi estetici,...

]]>

]]> PRNewswire it PR Newswire Association LLC. http://www.prnewswire.com/news-releases/syneron-introduces-enhancements-to-its-innovative-body-shaping-products-207698541.html http://www.prnewswire.com/news-releases/syneron-introduces-enhancements-to-its-innovative-body-shaping-products-207698541.html Thu, 16 May 2013 09:00:00 EDT YOKNEAM, Israel, May 16, 2013 /PRNewswire/ --   Expands treatment capabilities, reduces treatment time, and improves overall experience with UltraShape and VelaShape systems Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today the...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/taigen-biotechnology-announces-submission-of-new-drug-application-for-nemonoxacin-in-taiwan-and-mainland-china-207655851.html http://www.prnewswire.com/news-releases/taigen-biotechnology-announces-submission-of-new-drug-application-for-nemonoxacin-in-taiwan-and-mainland-china-207655851.html Thu, 16 May 2013 00:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/simponi-golimumab-receives-fda-approval-for-ulcerative-colitis-207595141.html http://www.prnewswire.com/news-releases/simponi-golimumab-receives-fda-approval-for-ulcerative-colitis-207595141.html Wed, 15 May 2013 16:15:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/bayer-receives-us-fda-approval-for-xofigo-radium-ra-223-dichloride-injection-as-a-new-treatment-for-castration-resistant-prostate-cancer-with-bone-metastases-207545191.html http://www.prnewswire.com/news-releases/bayer-receives-us-fda-approval-for-xofigo-radium-ra-223-dichloride-injection-as-a-new-treatment-for-castration-resistant-prostate-cancer-with-bone-metastases-207545191.html Wed, 15 May 2013 11:40:00 EDT WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Xofigo® (radium Ra 223 dichloride) for the treatment of patients with castration-resistant prostate cancer...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/mylan-launches-generic-zomig-tablets-207545181.html http://www.prnewswire.com/news-releases/mylan-launches-generic-zomig-tablets-207545181.html Wed, 15 May 2013 11:40:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/mies-pet-scintron-receives-fda-approval-207520051.html http://www.prnewswire.com/news-releases/mies-pet-scintron-receives-fda-approval-207520051.html Wed, 15 May 2013 08:56:00 EDT HOUSTON, May 15, 2013 /PRNewswire-iReach/ -- Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) are pleased to announce that the ECAT Scintron has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). MiE along with NIS will showcase this product at...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/twi-pharmaceuticals-announces-tentative-anda-approval-for-guanfacine-hydrochloride-extended-release-tablets-207344291.html http://www.prnewswire.com/news-releases/twi-pharmaceuticals-announces-tentative-anda-approval-for-guanfacine-hydrochloride-extended-release-tablets-207344291.html Tue, 14 May 2013 07:54:00 EDT en-US PR Newswire Association LLC.